Advertisement
UK markets close in 4 hours

  • FTSE 100

    8,091.15
    +50.77 (+0.63%)
     

  • FTSE 250

    19,708.69
    -10.68 (-0.05%)
     

  • AIM

    754.87
    +0.18 (+0.02%)
     

  • GBP/EUR

    1.1663
    +0.0018 (+0.15%)
     

  • GBP/USD

    1.2514
    +0.0052 (+0.42%)
     

  • Bitcoin GBP

    51,025.15
    -2,183.68 (-4.10%)
     

  • CMC Crypto 200

    1,353.09
    -29.48 (-2.13%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     

  • GOLD FUTURES

    2,341.60
    +3.20 (+0.14%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,954.01
    -134.69 (-0.74%)
     

  • CAC 40

    8,018.20
    -73.66 (-0.91%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Outlook on the Multiplex Assay Global Market to 2028 - Adoption of Personalized Medicines is Driving Growth

Research and Markets
·6-min read

Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Multiplex Assay Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The publisher suggests that the global market for multiplex assay is estimated to experience growth at a CAGR of 8.67% over the forecast period 2021-2028.

Factors such as the growing adoption of personalized medicines, coupled with the high adoption of multiplex assays over conventional methods, are supplementing the growth of the studied market.

Additionally, the rise in function by various government agencies and opportunities in emerging economies are opening new avenues for the global market. However, the shortage of skilled professionals and legal trends pertaining to environmental safety hamper the multiplex assay market's growth.

Regional Outlook

The global multiplex assay market covers the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.

Geographically, the Asia-Pacific is estimated to become the fastest-growing region in the multiplex assay market over the forecast market. The market's growth is mainly owing to the ever-increasing demand for healthcare services, coupled with the rise in the number of hospitals in countries like India and China. Moreover, the development of research and development infrastructure is anticipated to offer new opportunities for the reviewed market. Other than this, the rise in healthcare reforms and technological advancements is another set of factors supporting the multiplex assay market's growth across the region.

Competitive Outlook

The leading companies in the multiplex assay market include Olink Proteomics AB, Thermo Fisher Scientific Inc, F Hoffmann La Roche, Luminex Corporation, Siemens Healthineers AG, Randox Laboratories Ltd, Abcam, Agilent Technologies Inc, Becton Dickinson and Company, Bio Techne corporation, Qiagen NV, Merck Millipore, Illumina Inc, Meso Scale Diagnostics LLC, Seegene Inc, and Bio Rad Laboratories Inc.

Siemens Healthineers AG operates as a subsidiary of Siemens AG. Its business line includes manufacturing medical, surgical, ophthalmic, and veterinary instruments with imaging, diagnostics, and services. Besides, it has pioneered computed tomography, MRI, molecular imaging, ultrasound, and imaging IT designs. Siemens has operations across various regions, such as Asia-Pacific, the Middle East and Africa, and North America, with headquarters in Bayern, Germany.

Key Topics Covered:

1. Global Multiplex Assay Market - Summary

2. Industry Outlook
2.1. Impact of COVID-19 on Multiplex Assay Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Key Buying Outlook
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Market Strategies
2.7.1. Contracts and Partnerships
2.7.2. Business Expansions, Announcements, & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. New Product Launches & Developments
2.8. Key Drivers
2.8.1. Adoption of Personalized Medicines
2.8.2. High Adoption of Multiplex Assays Over Traditional Methods
2.9. Key Restraints
2.9.1. Dearth of Skilled Professionals
2.9.2. Legal Trends Related to Environmental Safety
2.10. Key Opportunities
2.10.1. Funding for R&D Activities by Various Government Agencies and Companies
2.10.2. Emerging Economies Offering Lucrative Growth Opportunities

3. Global Multiplex Assay Market - by Product and Service
3.1. Reagents and Consumables
3.2. Instruments and Accessories
3.3. Software and Services

4. Global Multiplex Assay Market - by Type
4.1. Protein-Based Multiplex Assay
4.2. Nucleic Acid-Based Multiplex Assay
4.3. Other Multiplex Assays

5. Global Multiplex Assay Market - by Application
5.1. Research and Development
5.2. Clinical Diagnostics
5.3. Companion Diagnostics

6. Global Multiplex Assay Market - by Technology
6.1. Multiplex Protein Microarray
6.2. Multiplex Pcr
6.3. Other Technologies

7. Global Multiplex Assay Market - by Industry Verticals
7.1. Pharmaceutical & Biotechnology Companies
7.2. Research Institutes
7.3. Clinical Laboratories
7.4. Hospitals

8. Global Multiplex Assay Market - Regional Outlook
8.1. North America
8.1.1. Market by Product and Service
8.1.2. Market by Type
8.1.3. Market by Application
8.1.4. Market by Technology
8.1.5. Market by Industry Verticals
8.1.6. Country Analysis
8.1.6.1. United States
8.1.6.2. Canada
8.2. Europe
8.2.1. Market by Product and Service
8.2.2. Market by Type
8.2.3. Market by Application
8.2.4. Market by Technology
8.2.5. Market by Industry Verticals
8.2.6. Country Analysis
8.2.6.1. Germany
8.2.6.2. France
8.2.6.3. United Kingdom
8.2.6.4. Italy
8.2.6.5. Russia
8.2.6.6. Spain
8.2.6.7. Rest of Europe
8.3. Asia-Pacific
8.3.1. Market by Product and Service
8.3.2. Market by Type
8.3.3. Market by Application
8.3.4. Market by Technology
8.3.5. Market by Industry Verticals
8.3.6. Country Analysis
8.3.6.1. China
8.3.6.2. Japan
8.3.6.3. India
8.3.6.4. Australia & New Zealand
8.3.6.5. South Korea
8.3.6.6. Asean Countries
8.3.6.7. Rest of Asia-Pacific
8.4. Latin America
8.4.1. Market by Product and Service
8.4.2. Market by Type
8.4.3. Market by Application
8.4.4. Market by Technology
8.4.5. Market by Industry Verticals
8.4.6. Country Analysis
8.4.6.1. Brazil
8.4.6.2. Mexico
8.4.6.3. Rest of Latin America
8.5. Middle East and Africa
8.5.1. Market by Product and Service
8.5.2. Market by Type
8.5.3. Market by Application
8.5.4. Market by Technology
8.5.5. Market by Industry Verticals
8.5.6. Country Analysis
8.5.6.1. Saudi Arabia
8.5.6.2. United Arab Emirates
8.5.6.3. Turkey
8.5.6.4. South Africa
8.5.6.5. Rest of Middle East & Africa

9. Competitive Landscape
9.1. Abcam
9.2. Agilent Technologies Inc
9.3. Becton Dickinson and Company
9.4. Bio Rad Laboratories Inc
9.5. Bio Techne Corporation
9.6. F Hoffmann La Roche
9.7. Illumina Inc
9.8. Luminex Corporation
9.9. Merck Millipore
9.10. Meso Scale Diagnostics LLC
9.11. Olink Proteomics Ab
9.12. Qiagen Nv
9.13. Randox Laboratories Ltd
9.14. Seegene Inc
9.15. Siemens Healthineers AG
9.16. Thermo Fisher Scientific Inc

10. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/vdye7p

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900